Receptor Activator of Nuclear Factor-B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

By Sasaki Atsushi   Ishikawa Kenji   Haraguchi Naotsugu   Inoue Hiroshi   Ishio Tetsuya   Shibata Kohei   Ohta Masayuki   Kitano Seigo   Mori Masaki  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1191-1199

Springer Publishing Company

Access to resources Recommend Favorite

Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton

By Mountzios Giannis   Dimopoulos Meletios-Athanassios   Bamias Aristotelis   Papadopoulos George   Kastritis Efstathios   Syrigos Konstantinos   Pavlakis George   Terpos Evangelos  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 221-229

Informa Healthcare

Access to resources Recommend Favorite

Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblasts

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 919-924

Spandidos Publications

Access to resources Recommend Favorite

Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factorκB ligand in osteoblasts in vivo and in vitro

By          

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 769-777

Spandidos Publications

Access to resources Recommend Favorite

Protective effects of the Tougu Xiaotong capsule on morphology and osteoprotegerin/nuclear factor-κB ligand expression in rabbits with knee osteoarthritis

By                      

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 419-425

Spandidos Publications

Access to resources Recommend Favorite